AI-Generated Evidence in Drug Discovery: Reliability, Legal Risk & FDA Compliance
The application of artificial intelligence-generated data in drug discovery raises new legal and regulatory questions. The article analyzes reliability, risks, and compliance with FDA regulations.
Relevance: 3 / 5
Open the original article in a new tab